Back to results
US 2024/0197743 A1Published application
Wee1 compound for treating uterine serous carcinoma
AssigneeRecurium IP Holdings, LLC
InventorsPhilippe Pultar, Dimitrios Voliotis, Marcus Rodrigues Viana, Fernando Donate, Petrus Rudolf de Jong, Ahmed Abdi Samatar, Kevin Duane Bunker, Peter Qinhua Huang
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for treating a subject having uterine serous carcinoma with a WEE1 inhibitor, or a pharmaceutically acceptable salt thereof.
Claims25
A method of treating a subject having uterine serous carcinoma (USC), the method comprising administering a therapeutically effective amount of ZN-c3, or a pharmaceutically acceptable salt thereof, to the subject in accordance with a dosing regimen.
Dependencies are inferred from the claim text.